Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4150-4155

  Guo, Lan ^a   Lu, Wanggui ^a   Zhang, Xuan ^a   Luo, Dixian ^a   Zhang, Hongwen ^b  

^a First People's Hospital of Chenzhou City   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cervical cancer; Lymph nodes metastasis; MACC1; Prognosis

Indexed keywords

MACC1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR;

ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84906259623     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Colombo N, Carinelli S, Colombo A, Marini C, Rollo D and Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 Suppl 7: vii27-32.
2. Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M and Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer 2012; 118: 4372-4384.
3. Cuzick J, Bergeron C, von Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, C JLMM, Sankaranarayanan R, P JFS and Szarewski A. New technologies and procedures for cervical cancer screening. Vaccine 2012; 30 Suppl 5: F107-116.
4. Ault KA. Cervical cancer prevention: better tests, better tools, and more equitable outcomes. J Natl Cancer Inst 2011; 103: 1352-1353.
5. Boulet GA, Horvath CA, Berghmans S and Bogers J. Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prev 2008; 17: 810-817.
6. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W and Schlag PM. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009; 15: 59-67.
7. Galimi F, Torti D, Sassi F, Isella C, Cora D, Gastaldi S, Ribero D, Muratore A, Massucco P, Siatis D, Paraluppi G, Gonella F, Maione F, Pisacane A, David E, Torchio B, Risio M, Salizzoni M, Capussotti L, Perera T, Medico E, Di Renzo MF, Comoglio PM, Trusolino L and Bertotti A. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 2011; 17: 3146-3156.
8. Boardman LA. Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 2009; 1: 36.
9. Stein U, Smith J, Walther W and Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 2009; 8: 2467-2469.
10. Kokoszynska K, Krynski J, Rychlewski L and Wyrwicz LS. Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 2009; 56: 317-323.
11. Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, Xu GL, Gao XD, Lou M, Lv JY and Yang YP. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2012; 18: 2995-3003.
12. Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T and Yasumoto K. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 2011; 141: 895-898.
13. Comoglio PM, Giordano S and Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008; 7: 504-516.
14. Arlt F and Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 2009; 41: 2356-2359.
15. Wang G, Kang MX, Lu WJ, Chen Y, Zhang B and Wu YL. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett 2012; 4: 783-791.
16. Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U and Janssen KP. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg 2012; 256: 763-771
17. Kawamura M, Saigusa S, Toiyama Y, Tanaka K, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y and Kusunoki M. Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res 2012; 32: 1527-1531.
18. Shirahata A, Fan W, Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 2011; 31: 777-780.